Authors

Latest:

Medical Marijuana Is a Trojan Horse That Pain Physicians Should Refuse to Accept

Forty-six percent of Americans want marijuana to be legalized. Seventy percent of Americans support the legalization of medical marijuana.

Sharmilan Thanendrarajan, MD

Latest:

Controversy Surrounds Treatment of High-Risk Smoldering Myeloma

A cure concept has not yet been established for asymptomatic and untreated patients with high-risk smoldering myeloma, and debate needs to be initiated surrounding how these patients can be treated sustainably while also taking into account their age, comorbidities, fitness, personal preference, and adverse events of the therapeutic agents.

Sharon Adarlo

Latest:

Tabernero Finds New Paths in Gastrointestinal Treatment Landscape

Josep Tabernero, MD, PHD, MSc, is best known for applying translational research against gastrointestinal tumors, with particular focus on colorectal cancer.

Sharon Francz, BHA

Latest:

Today's Nurse Navigator: Educating and Advocating for Cancer Patients

As both patient advocate and educator, the ONN partners with physicians to help support the cancer patient's journey throughout the course of disease, with the ultimate goal of improving care and outcomes.

Sharon Francz, LPN, BHA

Latest:

Compassion Fatigue: When Caring Takes Its Toll

Every day, oncology nurses provide care to patients who rely on them not only for their physical care, but also emotional and even spiritual care.

Sharon Sa

Latest:

Changes in Prostate Cancer Presentation for Radiation Oncology Care

USPSTF guidelines may have decreased the number of patients presenting with prostate cancer for radiation oncology care, particularly those with low-risk disease, without a short-term increase in higher-risk disease.

Sharon Spencer, MD

Latest:

Dr. Spencer on Radiation Therapy for Patients With Head and Neck Cancer

Sharon Spencer, MD, professor, chief of Medical Services, Ruby Meredith Outstanding Clinician Endowed Chair, University of Alabama at Birmingham School of Medicine, discusses the types of radiation therapy available to patients with head and neck cancer.

Sharyn Lewin, MD, FACS

Latest:

Dr. Lewin on the Impact of COVID-19 on Cancer Care

Sharyn Lewin, MD, FACS, discusses the impact of the coronavirus disease 2019 (COVID-19) on cancer care.

Sharyn N. Lewin, MD, Holy Name Medical Center

Latest:

Ovarian Cancer: Evolving Concepts Around Systemic Therapy

Shayma Kazmi, MD

Latest:

Dr. Kazmi Discusses Olanzapine for Breakthrough CINV

Dr. Shayma Kazmi, from Cancer Treatment Centers of America, on Olanzapine for Breakthrough Chemotherapy-Induced Nausea and Vomiting

Shayna L. Showalter, MD

Latest:

UVA Explores Same-Day Brachytherapy With Surgery for Early Breast Cancer

The University of Virginia Cancer Center has developed a new method for delivering radiation therapy along with less invasive surgery in a more precise and personalized manner.

Shayna Sarosiek, MD

Latest:

New Advances in Waldenström Macroglobulinemia

Understanding Waldenström Macroglobulinemia, and genomic profiles influencing clinical presentation and treatment strategies.

Shebli Atrash, MD

Latest:

Dr. Atrash on the Evolution of BCMA-Directed Therapies in Multiple Myeloma

Shebli Atrash, MD, discusses the development and current use of BCMA-targeted antibody-drug conjugates and CAR T-cell therapies for the treatment of patients with multiple myeloma.

Sheetal Kircher, MD

Latest:

Healthcare Reform and the Future of Oncology

The healthcare system in the United States has become increasingly unsustainable.

Sheetal M. Kircher, MD

Latest:

Day in the Life of an Oncology Fellow

When my alarm goes off at 5:30 am, I wake up prepared to play many roles. Juggling family life with 2 young children, caring for my patients as a fellow, and pursuing scholarly activities leaves little free time.

Sheila Ridner, PhD, RN

Latest:

PrimeMD, a Pain Reporting Smartphone Application for Patients Undergoing Head and Neck Radiation

A feasibility study of a smartphone application that patients undergoing radiation therapy for head and neck cancer can use to regularly report mucositis symptoms.

Shell Portner, RN, BSN

Latest:

Treatment Ends, but the Need for Care Continues

Celebration at the end of cancer treatment is often premature.

Shella Saint Fleur-Lominy, MD, PhD

Latest:

Dr Fleur-Lominy on Ongoing Research Within CML at the 2024 ASCO Annual Meeting

Shella Saint Fleur-Lominy, MD, PhD, and Yan Leyfman, MD, discuss ongoing research within the chronic myeloid leukemia patient population.

Shereen Stutz, RPH

Latest:

The FDA Could Help Address Financial Toxicity During the Approval Process

Given the widespread financial impact the high cost of cancer drugs has on the healthcare system, it may be time for the FDA to take a broader approach when reviewing oncology drug applications. By also examining the cost of the drug, the FDA could shine a light on escalating drug costs and play a leadership role in creating new programs and initiatives that help patients pay for promising new therapies.

Sherene Loi, MD, PhD

Latest:

Dr. Loi on the Association Between TILs and Trastuzumab

Sherene Loi, MD, PhD, on the association between immune cells and a pathologic complete response in patients with breast cancer after being given chemotherapy and trastuzumab.